Klotho Neurosciences, Inc.
KLTO · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $29 | $38 | $6 | $13 |
| - Cash | $7 | $8 | $1 | $0 |
| + Debt | $0 | $0 | $2 | $0 |
| Enterprise Value | $21 | $30 | $7 | $13 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$2 | -$2 | -$2 | -$2 |
| % Margin | – | – | – | – |
| Net Income | -$3 | -$4 | -$2 | -$2 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.049 | -0.12 | -0.081 | -0.076 |
| % Growth | 59.4% | -47.8% | -6.4% | – |
| Operating Cash Flow | -$1 | -$2 | -$2 | -$1 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$1 | -$2 | -$2 | -$1 |